Aeglea BioTherapeutics, Inc. (AGLE) .
本页证实的标准:
SharesGrow 综合评分： 34/100 其中 1/7 项标准通过。
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2015 | $-24.71 | $6.09M | $-11.3M | -185.6% |
| 2016 | $-55.40 | $4.63M | $-21.7M | -468.8% |
| 2017 | $-45.01 | $5.21M | $-27.24M | -523.3% |
| 2018 | $-53.25 | $3.89M | $-44.35M | -1140.6% |
| 2019 | $-59.23 | $0.00 | $-75.69M | - |
| 2020 | $-37.61 | $0.00 | $-80.3M | - |
| 2021 | $-25.02 | $18.74M | $-65.8M | -351.1% |
| 2022 | $-24.86 | $2.33M | $-83.82M | -3598.8% |
| 2024 | $-0.56 | $0.00 | $-208.02M | - |
| 2025 | $-1.98 | $0.00 | $-155.2M | - |
